Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study

American Journal of Clinical Nutrition

Volumn 63, Issue 3, 1996, Pages 306-314

  Riggs, Karen M ^a   Spiro III, Avron ^b   Tucker, Katherine ^b   Rush, David ^b  

^a TUFTS UNIVERSITY   (United States)

^b NONE

Author keywords

age; cognition; folate; homocysteine; psychological testing; Vitamin B 12; vitamin B 6

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; PYRIDOXINE;

ADULT; AGED; AGING; ARTICLE; BEHAVIOR; BRAIN FUNCTION; COGNITION; COGNITIVE DEFECT; HUMAN; HUMAN EXPERIMENT; MEMORY; PSYCHOLOGIC TEST; VASCULAR DISEASE; VITAMIN BLOOD LEVEL;

EID: 0029865065     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/63.3.306     Document Type: Article

References (54)

1. Martin DC. B-12 and folate deficiency dementia. Clin Geriatr Med 1988;4:841-52.
2. Abou-Saleh MT, Coppen A. The biology of folate in depression: implications for nutritional hypotheses of the psychoses. J Psychiatr Res 1986;20:91-101.
3. Sauberlich HE. Relationship of vitamin B-6, vitamin B-12, and folate to neurological and neuropsychiatric disorders. In: Bendich A, Butterworth CE Jr, eds. Micronutrients in health and in disease prevention. New York: Marcel Dekker, Inc, 1991:187-218.
4. Bohnen N, Jolles J, Degenaar CP. Lower blood levels of vitamin B-12 are related to decreased performance of healthy subjects in the Stroop Color-Word Test. Neurosci Res Commun 1992;11:53-6.
5. Goodwin JS, Goodwin JM, Carry PJ. Association between nutritional status and cognitive functioning in a healthy elderly population. JAMA 1983;249:2917-21.
6. Ubbink JB, Vermaak WJH, van der Merwe A, Becker PJ. Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia. Am J Clin Nutr 1993;57:47-53.
7. Selhub J, Jacques PJ, Wilson PWF, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in the elderly. JAMA 1993;270:2693-8.
8. Allen RH, Stabler SP, Savage DG, Lindenbaum J. Diagnosis of cobalamin deficiency. I Usefulness of serum methylmalonic acid and total homocysteine concentrations. Am J Hematol 1990;34:90-8.
9. Joosten E, van den Berg A, Riezler R, et al. Metabolic evidence that deficiencies of vitamin B-12 (cobalamin), folate, and vitamin B-6 occur commonly in elderly people Am J Clin Nutr 1993;58:468-76.
10. Lindenbaum J, Rosenberg IH, Wilson PWF, Stabler SP, Allen RH. Prevalence of cobalamin deficiency in the Framingham elderly population. Am J Clin Nutr 1994;60:2-11.
11. Mudd SH, Levy HL, Skovby F. Disorders of transulfuration. In: Scriver C, Beaudet AL, Sly WS, Valle D, eds. The metabolic basis of inherited disease, 6th ed. Vol A. New York: McGraw-Hill, 1989:693-734.
12. Wilcken DEL, Dudman NPB, Tyrrell PA, Robertson MR. Folic acid lowers elevated plasma homocysteine in chronic renal insufficiency: possible implications for prevention of vascular disease. Metabolism 1988;37:697-701.
13. Jacques PJ, Riggs KM. B vitamins as risk factors for age-related diseases. In: Rosenberg IH, ed. Nutritional assessment of elderly populations. Measure and function. New York: Raven Press, 1995.
14. Berg S. Psychological functioning in 70- and 75-year old people. Acta Psychiatr Scand 1980;Suppl 288:1-47.
15. Botwinick J, Storandt M. Memory, related functions and age. Springfield, IL: Charles C Thomas, 1974.
16. Hertzog C, Schaie KW, Gribbin K. Cardiovascular disease and changes in intellectual functioning from middle to old age. J Gerontol 1978;33:872-83.
17. Rinn WE. Mental decline in normal aging: A review. J Geriatr Psychiatry Neurol 1988;1:144-58.
18. Spieth W. Slowness of task performance and cardiovascular disease. In: Welford AT, Birren JE, eds. Behavior, aging and the nervous system. Springfield, IL: Charles C Thomas, 1965:366-400.
19. O'Brien MD. How does cerebrovascular disease cause dementia? Dementia 1994;5:133-6.
20. Araki A, Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr 1987;422:43-52.
21. Shin-Buehring Y, Rasshofer R, Endres W. A new enzymatic method for pyridoxal-5′-phosphate determination. J Inherit Metab Dis 1981; 4 123-4.
22. Morris JC, Heyman A, Mohs RC, et al. The consortium to establish a registry for Alzheimer's disease (CERAD). Part I Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989; 39:1159-65.
23. Letz R. NES2 user's manual (version 4.4). Winchester, MA: Neurobehavioral Systems, Inc, 1991.
24. Wechsler DA. Manual for the Wechsler Adult Intelligence Scale - revised. New York: Psychological Corporation, 1981.
25. Eisen EA, Letz RA, Wegman DH, Baker Jr EL, Pothier L. Defining measurement precision for effort dependent tests: the case of three neurobehavioral tests. Int J Epidemiol 1988;17:920-6.
26. Welsh KA, Butters N, Mohs RC, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part V. A normative study of the neuropsychological battery. Neurology 1994;44:609-14.
27. Salthouse TA, Kausler DH, Saults JS. Investigation of student status, background variables, and feasibility of standard tasks in cognitive aging research. Psychol Aging 1988;3:29-37.
28. Beery KE. The developmental test of visual-motor integration manual. Revised ed. Cleveland: Modern Curriculum Press, 1989.
29. Folstein MF, Folstein SE, McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
30. Salthouse TA, Babcock RL, Mitchell DRD, Palmon R, Skovronek E. Sources of individual differences in spatial visualization ability. Intelligence 1990,14:187-230.
31. McLain DH. Drawing contours from arbitrary data points. Comput J 1974;17.318-24.
32. Wilkinson L SYGRAPH. The system for graphics. Evanston, IL: SYSTAT, Inc. 1990.
33. de Haes JC, de Ruiter JH, Tempelaar R, Pennink BJ. The distinction between affect and cognition in the quality of life of cancer patients: sensitivity and stability. Qual Life Res 1992;1:315-22.
34. Tun PA, Nathan DM, Perlmuter LC. Cognitive and affective disorders in elderly diabetics. Clin Geriatr Med 1990;6:731-46.
35. Elias MF, Robbins MA, Schultz Jr NR, Pierce TW. Is blood pressure an important variable in research on aging and neuropsychological test performance? J Gerontol Psychol Sci 1990;45:P128-35.
36. van Swieten JC, Geyskes GG, Derix MMA, et al. Hypertension in the elderly is associated with white matter lesions and cognitive decline. Ann Neurol 1991;30:825-30.
37. Miller JW, Ribaya-Mercado JD, Russell RM, et al Effect of vitamin B-6 deficiency on fasting plasma homocysteine concentrations. Am J Clin Nutr 1992;55:1154-60.
38. Thompson WG, Babitz L, Cassino C, et al. Evaluation of current criteria used to measure vitamin B-12 levels. Am J Med 1987;82: 291-4.
39. Leklem JE. Vitamin B-6. A status report. J Nutr 1990;120:1503-7.
40. Rosenberg IH, Bowman BB, Cooper BA, et al. Folate nutrition in the elderly. Am J Clin Nutr 1982;6:1067-82.
41. US Public Health Service International Classification of Diseases. 8th revision. Adapted for use in the United States. Washington, DC: US Government Printing Office, 1968. (USPHS publication 1693.)
42. Storandt M, Botwinick J, Danziger WL. Longitudinal changes: patients with mild SDAT and matched healthy controls. In: Poon LW, ed. Handbook for clinical memory assessment of older adults. Washington, DC: American Psychological Association, 1986:277-84.
43. Schultz TD, Leklem JE. Supplementation and vitamin B-6 metabolism. In: Reynolds RD, Leklem JE, eds. Vitamin B-6: its role in health and disease. New York: Alan R Liss, Inc, 1985:419-27.
44. Carney MWP, Toone BK, Reynolds EH. S-Adenosylmethionine and affective disorder. Am J Med 1987;83(suppl 5A):104-6.
45. Levitt AJ, Joffe RT. Folate, vitamin B-12, and life course of depressive illness. Biol Psychiatry 1989;25:867-72.
46. Shane B, Stokstad ELR Vitamin B-12-folate interrelationships. Annu Rev Nutr 1985;5:115-41.
47. Dakshinamurti K, Paulose CS, Siow YL. Neurobiology of pyridoxine. In: Reynolds RD, Leklem JE, eds. Vitamin B-6: its role in health and disease. New York: Alan R Liss, Inc, 1985:99-121.
48. Harker LA, Ross R, Slichter SJ, Scott CR. Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis. J Clin Invest 1976;58:731-41.
49. Selhub J, Jacques PF, Bostom AG, et al. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med 1995;332:286-91.
50. Lindgren A, Brattstrom L, Hultberg B. Plasma homocysteine and white matter abnormalities of the brain. Ir J Med Sci 1995;164(suppl 15):26.
51. Bell IR, Edman JS, Selhub J, et al. Plasma homocysteine in vascular disease and in nonvascular dementia of depressed elderly people. Acta Psychiatr Scand 1992;86:386-90.
52. Beal MF, Swartz KJ, Finn SF, Mazurek MF, Kowall NW. Neurochemical characterization of excitotoxin lesions in the cerebral cortex. J Neurosci 1991;11:147-58.
53. Shorvon SD, Carney MWP, Chanarin I, Reynolds EH. The neuropsychiatry of megaloblastic anaemia. Br Med J 1980;281:1036-8.
54. Shay KA, Roth DL. Association between aerobic fitness and visuospatial performance in healthy older adults. Psychol Aging 1992;7:15-24.